ArticleEnvironment & health (Washington, D.C.)2024
Evaluation of Machine Learning Based QSAR Models for the Classification of Lung Surfactant Inhibitors.
Article in Environment & health (Washington, D.C.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Tutorial on Best Practices and Pitfalls in Applying Machine Learning to Environmental Research.ACS environmental Au · 2026Article
- Integrative deep learning strategies to enhance early-stage drug discovery: optimizing computational structure-activity modeling for pharmacotherapeutic innovation.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inhaled chemicals can cause dysfunction in the lung surfactant, a protein-lipid complex with critical biophysical and biochemical functions. This inhibition has many structure-related and dose-dependent mechanisms, making hazard identification challenging. We developed quantitative structure-activity relationships for predicting lung surfactant inhibition using machine learning. Logistic regression, support vector machines, random forest, gradient-boosted trees, prior-data-fitted networks, and multilayer perceptron were evaluated as methods. Multilayer perceptron had the strongest performance with 96% accuracy and an F1 score of 0.97. Support vector machines and logistic regression also performed well with lower computation costs. This serves as a proof-of-concept for efficient hazard screening in the emerging area of lung surfactant inhibition.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.